Isomorphic Labs vs Recursion Pharmaceuticals: AI supply-chain exposure compared
Recursion Pharmaceuticals carries the heavier AI-chain exposure (Isomorphic Labs 40/100 vs Recursion Pharmaceuticals 41/100). They share 3 parts of the chain — including GPU, Inference serving, Agent workflow. Each owns 0 binding nodes.
Based on 3 mapped exposures for Isomorphic Labs and 3 for Recursion Pharmaceuticals.
- Chain weight
- 40/100
- Parts exposed
- 3
- Layers spanned
- 3
- Bottlenecks owned
- 0
Recursion PharmaceuticalsRXRX · Applications- Chain weight
- 41/100
- Parts exposed
- 3
- Layers spanned
- 3
- Bottlenecks owned
- 0
Where they overlap
Frequently asked
Is Isomorphic Labs or Recursion Pharmaceuticals more exposed to the AI supply chain?
Recursion Pharmaceuticals, on the model's chain-weight (Isomorphic Labs 40/100 vs Recursion Pharmaceuticals 41/100).
What do Isomorphic Labs and Recursion Pharmaceuticals have in common in the AI chain?
Both are exposed to GPU, Inference serving, Agent workflow.
How is this Isomorphic Labs vs Recursion Pharmaceuticals comparison made?
From THE ENTITY's model of the AI value chain — each company's exposures to the parts of the chain, weighted by how central those parts are and its role. Structural, not a price target.
A structural comparison from our model of the AI value chain — illustrative, not investment advice.